This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Neptune Reports Second Quarter Results

LAVAL, Quebec, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) reports today its consolidated financial results for the three- and six-month periods ended August 31, 2012.

Six month ended August 31, 2012 Financial Results

Nutraceutical Business Results

  • Nutraceutical revenues increased by 62% to $14,001,000, for the six-month period ended August 31, 2012, up from $8,636,000 achieved during the corresponding period ended August 31, 2011.
  • EBITDA from nutraceutical business for the six-month period ended August 31, 2012 increased by 26% to $1,793,000, up from $1,424,000 obtained during the corresponding period ended August 31, 2011.
  • Net loss from nutraceutical business reached $2,749,000 for the six-month period ended August 31, 2012, compared to a net income of $136,000 for the corresponding period ended August 31, 2011.

Consolidated Results

  • Revenues increased by 65% to $14,252,000 for the six-month period ended August 31, 2012, up from $8,636,000 achieved during the corresponding period ended August 31, 2011.
  • Consolidated EBITDA for the six-month period ended August 31, 2012 was ($562,000), compared to ($1,076,000) obtained during the corresponding period ended August 31, 2011.
  • Earnings for the six-month period ended August 31, 2012 resulted into a net loss of ($6,379,000) compared to a net loss of ($3,026,000), for the corresponding period ended August 31, 2011.

"The good progression of our stock price during Q2 2013 had its good and bad sides. Our stock price increased by approximately 20%, which had a direct impact on our stock-based compensation expenses. Because of IFRS standards, stock-option granted to consultants have to be reevaluated every quarter, impacting directly the bottom line. This is a blessing in disguise, because stock price appreciation benefits everyone," said Frédéric Harland, Director Finance.

"Neptune had a strong and record-breaking fiscal year 2012 and the momentum has kept on in the first and second quarter of fiscal 2013," said André Godin, CFO. "Our aggressive policy of volume discount combined with some product reprocessing has contributed to slightly reduce our gross margin percentage for this quarter. This one-time approach has still produced an overall increase in the gross margin in dollar and was mainly put in place to secure market share," he added.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs